Development and validation of a high-performance liquid chromatographic method for analysis of nimesulide residues on manufacturing equipment surfaces

• Autorzy: Milenović, D. M. , Todorović, Z. B.
• Języki publikacji: EN

Abstrakty

EN

In the pharmaceutical industry it is important to remove drug residues from the equipment and areas used. Cleaning procedures must be validated, so special attention must be devoted to the methods used for analysis of trace amounts of drugs. To monitor a cleaning procedure, a high-performance liquid chromatographic method for analysis of nimesulide residues in swab samples has been developed and validated. The swabbing procedure was optimized to achieve suitable recovery of nimesulide from stainless steel. Mean recovery was >80% when two swabs were used. The precision of the results, reported as the relative standard deviation (RSD), was <2.00%. The method was validated over the concentration range 0.30–50.00 μg mL ^-1. Small amounts of the drug residues were analysed by HPLC with an ODS column (250 mm × 4.6 mm, 5-μm particles), at 20°C, with 65:35:3:0.13 ( v/v/v/w ) methanol-water-phosphate buffer (pH 3; 0.05 M )-sodium heptane sulfonate as mobile phase at a flow rate of 0.8 mL min ^-1. Nimesulide was detected at 235 nm. This procedure enabled simple, sensitive, and convenient HPLC analysis of nimesulide residues on stainless steel.

Słowa kluczowe

EN

cleaning validation; nimesulide; swab analysis; residues on surfaces

• Czasopismo: Acta Chromatographica
• Rocznik: 2009
• Tom: Vol. 21, no. 4
• Strony: 603--618
• Opis fizyczny: Bibliogr. 21 poz., rys., tab.

Twórcy

autor

Milenović, D. M.

• Zdravlje-Actavis Company, R&D Analytical Department 16000 Leskovac Serbia,

autor

Todorović, Z. B.

• University of Niš Faculty of Technology 16000 Leskovac Serbia

Bibliografia

• [1] Guide to Inspections Validation of Cleaning Processes, U.S. Food and Drug Administration available at: http://www.fda.gov/ICECI/Inspections/InspectionGuides/ucm074922.htm (accessed 27/10/2009)
• [2] World Health Organization, Supplementary guidelines on good manufacturing practices (GMP): Validation, Working document QAS/03.055/Rev.2, pp 24–33, available at: http://www.who.int/medicines/services/expertcommittees/pharmprep/Validation_QAS_055_Rev2combined.pdf (accessed 10 Oct, 2009)
• [3] Guidance on aspects of cleaning validation in active pharmaceutical ingredient plants, Active Pharmaceutical Ingredients Committee (APIC), pp 1–56, available at: http://apic.cefic.org/pub/pub-cleaning-validation.pdf (accessed 10 Oct, 2009)
• [4] D.A. Leblanc, Pharm. Technol., 22 , 136–148 (1998)
• [5] G.L. Fourman and M.W. Mullen, Pharm. Technol., 17 , 54–60 (1993)
• [6] B. Tubić, B. Ivković, M. Zečević, and S. Vladimirov, Acta Chim. Slov. 54 , 583–590 (2007)
• [7] A. Maltese, F. Maugeri, and C. Bucolo, J. Chromatogr. B, 804 , 441–443 (2004)
• [8] D.J. Jaworowitz Jr, M.T. Filipowski, and K.M.K. Boje, J. Chromatogr. B, 723 , 293–299 (1999)
• [9] V.B. Patravale, S. D’souza, and Y. Narkar, J. Pharm. Biomed. Anal., 25 , 685–688 (2001)
• [10] P.D. Tzanavaras and D.G. Themelis, J. Pharm. Biomed. Anal., 43 , 1483–1487 (2007)
• [11] S. Altinöz and Ö.Ö. Dursun, J. Pharm. Biomed. Anal., 22 , 175–182 (2000)
• [12] P. Kovarikova, M. Mokry, and J. Klimeš, J. Pharm. Biomed. Anal., 31 , 827–832 (2003)
• [13] G. Khaksa and N. Udupa, J. Chromatogr. B, 727 , 241–244 (1999)
• [14] M. Carini, G. Aldini, R. Stefani, C. Marinello, and R.M. Facino, J. Pharm. Biomed. Anal., 18 , 201–211 (1998)
• [15] M.J. Nozal, J.L. Bernal, J.J. Jimenez, M.T. Martin, and F.J. Diez, J. Chromatogr. A, 1024 , 115–122 (2004)
• [16] M.J. Nozal, J.L. Bernal, L. Toribio, M.T. Martin, and F.J. Diez, J. Pharm. Biomed. Anal., 30 , 285–291 (2002)
• [17] J. Lambropoulos, G.A. Spanos, and N.V. Lazaridis, J. Pharm. Biomed. Anal., 23 , 421–428 (2000)
• [18] M.B. Boca, Z. Apostolides, and E. Pretorius, J. Pharm. Biomed. Anal., 37 , 461–468 (2005)
• [19] R. Klinkenberg, B. Streel, and A. Ceccato, J. Pharm. Biomed. Anal., 32 , 345–352 (2003)
• [20] T. Mirza, M.J. Lunn, F.J. Keeley, R.C. George, and J.R. Bodenmiller, J. Pharm. Biomed. Anal., 19 , 747–756 (1999)
• [21] International Conference on Harmonization Q2 (R1): Validation of Analytical Procedures: Text and Methodology, available at: http://www.ich.org/cache/compo/276-254-1.html (accessed 10 Oct, 2009)